PharmaZell gladly informs that we have received US-FDAs approval for our DMF-Type-II for our Product Teriflunomide.
The construction of our new buildings in gropello continues apace.
We are pleased to announce that PharmaZell(India)Private Limited has been awarded EcoVadis Silver Medal in Recognition for Sustainability Performance. This Recognition places our company among the top 25 percent of companies assessed by EcoVadis.
New expansion of fully automated and dedicated Production facility for Mesalamine has picked up its momentum at Visakhapatnam site. It is targeted to start the production in October-2021. Impact of COVID-19 lead to few disturbances for 2-3 weeks, however there are adeuqate buffer time in plan to mitigate potential delays. Majority of the equipment are
20 April 2021, Gropello. Farmabios Spa, part of the PharmaZell Group, is pleased to announce it has received validation from the European Commission (“EC”), and European Food Safety Authority (“EFSA”) for the dossier on synthetic CBD as a Novel Food.
Despite all restrictions and taking into account the COVID regulations, CEO Dr. Bolzern did not miss the opportunity to attend the celebration of the 25th anniversary of the PharmaZell Group site Chennai (India).
CEO Dr. Oliver Bolzern visited the Visakhapatnam site in February. He appreciated the various measures and efforts taken during COVID pandemic which has helped to restrict any potential disturbance in the operations.